Overview
- Maximizes reader insights into recent breakthrough in drug treatment
- Describes drug development from bench to clinic
- Treats both basic research and clinical applications
- Includes supplementary material: sn.pub/extras
Part of the book series: Milestones in Drug Therapy (MDT)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (14 chapters)
-
Front Matter
-
Drugs to Treat Insomnia
-
Front Matter
-
-
Drugs to Treat Excessive Daytime Sleepiness
-
Front Matter
-
-
Drugs to Treat Circadian Sleep Disorders
-
Front Matter
-
-
Conclusive Remarks
-
Front Matter
-
Keywords
About this book
Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.
Reviews
“This book explores major breakthroughs in the drug treatment of sleep disorders. … The intended audience is scientists, clinicians, and drug developers. … With its specific aim of providing an extensive update on drug treatment for sleep disorders, this book is helpful contribution to sleep medicine.” (M. Isabel L. Crisostomo, Doody’s Book Reviews, July, 2015)
Editors and Affiliations
Bibliographic Information
Book Title: Drug Treatment of Sleep Disorders
Editors: Antonio Guglietta
Series Title: Milestones in Drug Therapy
DOI: https://doi.org/10.1007/978-3-319-11514-6
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer International Publishing Switzerland 2015
Hardcover ISBN: 978-3-319-11513-9Published: 11 December 2014
Softcover ISBN: 978-3-319-37920-3Published: 23 August 2016
eBook ISBN: 978-3-319-11514-6Published: 28 November 2014
Series ISSN: 2296-6056
Series E-ISSN: 2296-6064
Edition Number: 1
Number of Pages: VIII, 297
Number of Illustrations: 9 b/w illustrations, 14 illustrations in colour
Topics: Pharmacology/Toxicology, Neurosciences, Pharmacotherapy, Psychopharmacology